An initial consultation with a gynaecologist is required to assess the baseline functional and aesthetic problems and whether surgical and/or medical treatment is needed before use of Viveve is possible.

We all know having kids places huge demands on our bodies. One of the most affected, yet least spoken about issue, is that of our vagina being stretched to the max and therefore creating a feeling of looseness and decreased feeling of sensation and sexual satisfaction during intercourse. In a survey of over four hundred women, nearly half reported some level of vaginal looseness, or what is known as vaginal laxity.

Viveve is a non-surgical vaginal treatment that tightens and tones the vaginal canal. The radio frequency energy combined with cryogen cooling penetrates through the mucosal tissues to act directly on the collagen layer to stimulate cellular collagen growth. Over a 12 week period, the collagen remodels and strengthens to support not only the vaginal tissues but also creates an improved collagen hammock under the urethra that acts a bit like a “natural” sling to decrease stress incontinence.

  • Performed in the comfort of our clinic

  • Typically takes 40 minutes

  • Well-tolerated and doesn’t require anaesthesia

  • Little to no downtime, you can go back to your normal activities following the procedure, with the exception of no sexual intercourse for 48 hours

Viveve can increase feelings of vaginal tightness. Treating the vaginal opening and the vulval tissues also provides a visible and cosmetic outcome. The partners of women we have treated commonly comment that intercourse feels more like it did prior to having kids.

In a sexual satisfaction survey of women who had undergone the Viveve treatment after experiencing vaginal deliveries, 67% of the women reported an increase in vaginal tightness at 30 days, and 87% at 6 months after the treatment. (Millheiser et al. (2010) 

To date the treatment has been tested in two prospective clinical trials in the USA and Japan which assessed the safety and efficacy of the treatment. The results from both studies showed that at 12 months after treatment vaginal tightness improved significantly (for 88% of women in the study), often to pre-childbirth levels, with a 68% mean increase in vaginal laxity scores, with no serious adverse effects reported in either study. (Aesthet Surg J. 2019)

Read about Viveve in this news.com.au article.

For more information check out the Viveve brochure.

 

Viveve

2019 © The ELSA CLINIC | Site by AFFINITY MARKETING